[Comment] Difficulty in predicting survival in metastatic renal cancer
01:11 EDT 7 Aug 2012 | The Lancet
Treatment of metastatic renal-cell carcinoma has a come a long way in a very short period of time. Seven approved targeted therapies exist, all of which arrived within about 5 years of each other. For various reasons, including crossover in the desig..
Original Article: [Comment] Difficulty in predicting survival in metastatic renal cancer
More From BioPortfolio on "[Comment] Difficulty in predicting survival in metastatic renal cancer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
